Mechanisms of nerve growth factor release from a human urothelial cell line

Peter Ochodnicky , Martin C. Michel , Martina B. Michel
The FASEB Journal 25

2011
Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response.

Peter Ochodnicky , Dick de Zeeuw , Robert H. Henning , Richard P. E. van Dokkum
Journal of Nephrology 19 ( 3) 246 -258

50
2006
Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.

Vaclav Vaja , Peter Ochodnicky , Peter Krenek , Jan Klimas
European Journal of Pharmacology 619 ( 1) 85 -91

12
2009
Desirable properties of β3-adrenoceptor agonists: implications for the selection of drug development candidates.

Martin C. Michel , Hana Cernecka , Peter Ochodnicky
European Journal of Pharmacology 657 1 -3

9
2011
Pycnogenol improves left ventricular function in streptozotocin-induced diabetic cardiomyopathy in rats.

Jan Klimas , Jana Kmecova , Stanislava Jankyova , Diana Yaghi
Phytotherapy Research 24 ( 7) 969 -974

16
2010
β-adrenoceptor agonist effects in experimental models of bladder dysfunction.

Martin C. Michel , Peter Ochodnicky , Yukio Homma , Yasuhiko Igawa
Pharmacology & Therapeutics 131 ( 1) 40 -49

24
2011
Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats

Jan Klimas , Michael Olvedy , Katarina Ochodnicka-Mackovicova , Peter Kruzliak
Journal of Cellular and Molecular Medicine 19 ( 8) 1965 -1974

71
2015
Microalbuminuria and endothelial dysfunction: emerging targets for primary prevention of end-organ damage.

Peter Ochodnicky , Robert H. Henning , Richard P.E. van Dokkum , Dick de Zeeuw
Journal of Cardiovascular Pharmacology 47 ( 2)

88
2006
28
2006
Tissue functions mediated by β3-adrenoceptors—findings and challenges

Martin C. Michel , Peter Ochodnicky , Roger J. Summers
Naunyn-Schmiedeberg's Archives of Pharmacology 382 ( 2) 103 -108

34
2010
Specificity evaluation of antibodies against human β3-adrenoceptors.

Hana Cernecka , Peter Ochodnicky , Wouter H. Lamers , Martin C. Michel
Naunyn-schmiedebergs Archives of Pharmacology 385 ( 9) 875 -882

30
2012
Excessive dietary lipid intake provokes an acquired form of lysosomal lipid storage disease in the kidney

Elena Rampanelli , Peter Ochodnicky , Johannes PC Vissers , Loes M Butter
The Journal of Pathology 246 ( 4) 470 -484

14
2018
High glucose induces HGF-independent activation of Met receptor in human renal tubular epithelium

Lucia Mesarosova , Peter Ochodnicky , Jaklien C. Leemans , Sandrine Florquin
Journal of Receptors and Signal Transduction 37 ( 6) 535 -542

9
2017
Renal endothelial function is associated with the anti-proteinuric effect of ACE inhibition in 5/6 nephrectomized rats.

Simone Vettoretti , Peter Vavrinec , Peter Ochodnicky , Leo E. Deelman
American Journal of Physiology-renal Physiology 310 ( 10) 1047 -1053

3
2016
Isoproterenol‐induced heart failure in the rat is associated with nitric oxide‐dependent functional alterations of cardiac function

Peter Krenek , Jana Kmecova , Dana Kucerova , Zuzana Bajuszova
European Journal of Heart Failure 11 ( 2) 140 -146

69
2009
Metabolic injury-induced NLRP3 inflammasome activation dampens phospholipid degradation

Elena Rampanelli , Evelyn Orsó , Peter Ochodnicky , Gerhard Liebisch
Scientific Reports 7 ( 1) 2861

19
2017
Enalaprilat increases PPARβ/δ expression, without influence on PPARα and PPARγ, and modulate cardiac function in sub-acute model of daunorubicin-induced cardiomyopathy.

Hana Cernecka , Katarina Ochodnicka-Mackovicova , Dana Kucerova , Jana Kmecova
European Journal of Pharmacology 714 ( 1) 472 -477

17
2013
Pioglitazone, a PPARγ agonist, provides comparable protection to angiotensin converting enzyme inhibitor ramipril against adriamycin nephropathy in rat

Peter Ochodnicky , Lucia Mesarosova , Hana Cernecka , Jan Klimas
European Journal of Pharmacology 730 51 -60

13
2014